Cargando…
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells
Canine mastocytomas (MCTs) are characterized by rapid proliferation of neoplastic mast cells (MCs) and clinical signs caused by MC‐derived mediators. In dogs suffering from MCT, histamine receptor 1 (HR1) antagonists are frequently used to control mediator‐related clinical symptoms. Previous studies...
Autores principales: | Gamperl, Susanne, Stefanzl, Gabriele, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840218/ https://www.ncbi.nlm.nih.gov/pubmed/32924324 http://dx.doi.org/10.1002/vms3.336 |
Ejemplares similares
-
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells
por: Gamperl, Susanne, et al.
Publicado: (2019) -
Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms
por: Willmann, Michael, et al.
Publicado: (2018) -
The uptake of 5-hydroxytryptamine, histamine, and their amino acid precursors by neoplastic mast cells.
por: Green, J. P.
Publicado: (1966) -
CYTOLOGICAL AND PHARMACOLOGICAL OBSERVATIONS ON THE RELEASE OF HISTAMINE BY MAST CELLS
por: Fawcett, Don W.
Publicado: (1954) -
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
por: Peter, Barbara, et al.
Publicado: (2017)